Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer (BC)

Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer

The purpose is to collect real life data on the use of fulvestrant in normal clinical practice in Austria and document the clinical benefit of fulvestrant treatment.

Inclusion Criteria:

• Postmenopausal women with hormone receptor-positive locally advanced or metastatic breast cancer
• Ability to read and write and complete questionnaires
• Provision of written informed consent
• Patients who already received a prescription for fulvestrant

Exclusion Criteria:

• A subject who does not fulfil all the above mentioned inclusion criteria is not allowed to participate in this NIS